Wird geladen...
Baseline monocyte and its classical subtype may predict efficacy of PD-1/PD-L1 inhibitor in cancers
Background: Programmed death 1 (PD-1)/ programmed death-ligand 1 (PD-L1) inhibitor is one of the most popular immune therapies. Biomarkers for predicting response are highly needed, but no biomarkers are widely used till now. Patients and methods: From February 2018 to April 2019, pan-cancer patient...
Gespeichert in:
| Veröffentlicht in: | Biosci Rep |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Portland Press Ltd.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7846968/ https://ncbi.nlm.nih.gov/pubmed/33440424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20202613 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|